NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations

World Journal of Gastroenterology

Volumn 13, Issue 19, 2007, Pages 2697-2702

  Al Moundhri, Mansour ^a   Al Kindi, Mohamed ^a   Al Nabhani, Maryam ^a   Al Bahrani, Bassim ^b   Burney, Ikram A ^a   Al Madhani, Ali ^c   Ganguly, Shyam S ^a   Tanira, Misbah ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b ROYAL HOSPITAL   (Oman)

^c Sohar Hospital   (Oman)

Author keywords

Arab; Gastric cancer; H pylori; NAT2; Omani; Polymorphism

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; BACTERIUM ANTIBODY; GENOMIC DNA; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; OMAN; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH SURGERY; UNIVARIATE ANALYSIS;

EID: 34250753726     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i19.2697     Document Type: Article

References (27)

1. Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev 2000; 26: 243-255
2. Minsitry of Health Sultanate of Oman: Cancer incidence in Oman. 2002: 28-31
3. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002; 100: 249-260
4. Correa P. New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility. J Surg Oncol 2005; 90: 134-138; discussion 138
5. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9
6. Gonzalez CA. Vegetable, fruit and cereal consumption and gastric cancer risk. IARC Sci Publ 2002; 156: 79-83
7. Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 1994; 120: 982-986
8. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402
9. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000; 9: 29-42
10. La Torre G, Boccia S, Ricciardi G. Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 2005; 217: 53-60
11. Taningher M, Malacarne D, Izzotti A, Ugolini D, Parodi S. Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res 1999; 436: 227-261
12. Boissy RJ, Watson MA, Umbach DM, Deakin M, Elder J, Strange RC, Bell DA. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Int J Cancer 2000; 87: 507-511
13. Katoh T, Boissy R, Nagata N, Kitagawa K, Kuroda Y, Itoh H, Kawamoto T, Bell DA. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int J Cancer 2000; 85: 46-49
14. Ladero JM, Agundez JA, Olivera M, Lozano L, Rodriguez-Lescure A, Diaz-Rubio M, Benitez J. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma. Eur J Clin Pharmacol 2002; 58: 115-118
15. Lan Q, Rothman N, Chow WH, Lissowska J, Don MA, Xiao GH, Zatonski W, Hein DW. No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 384-386
16. Suzuki S, Muroishi Y, Nakanishi I, Oda Y. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 2004; 39: 220-230
17. Tanira MOM SM, Al Balushi K, Al Lawatia K, Al Barawani H, Bayoumi RA,: Distribution of arylamine N-acetyltransferase 2 (NAT2) genotypes among Omanis. SQU Journal for Scientific Research: Medical Sciences 2003; 5: 9-14
18. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-253
19. Haldane JB: The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956; 20: 309-311
20. Mantel N, Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748
21. Woodhouse NM, Qureshi MM, Bastaki SM, Patel M, Abdulrazzaq Y, Bayoumi RA. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis. Pharmacogenetics 1997; 7: 73-82
22. Tsuji S, Tsujii M, Murata H, Nishida T, Komori M, Yasumaru M, Ishii S, Sasayama Y, Kawano S, Hayashi N. Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms. World J Gastroenterol 2006; 12: 1671-1680
23. Macarthur M, Hold GL, El-Omar EM. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004; 286: G515-G520
24. Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12: 2979-2990
25. Yajima N, Hiraishi H, Yamaguchi N, Ishida M, Shimada T, Terano A. Monochloramine-induced cytolysis to cultured rat gastric mucosal cells: role of glutathione and iron in protection and injury. J Lab Clin Med 1999; 134: 372-377
26. Kim HS, Kwack SJ, Lee BM. Alteration of cytochrome P-450 and glutathione S-transferase activity in normal and malignant human stomach. J Toxicol Environ Health A 2005; 68: 1611-1620
27. Hung CF, Chung JG, Liu SI, Hung H. Arylamine N-acetyltransferase: a possible promoter in Helicobacter pylori-related gastric carcinogenesis. Zhonghua Yixue Zazhi (Taipei) 1999; 62: 203-208